Most Recent Articles by John M. Kane, MD
John Kane, MD, considers prevention and treatment approaches for mood disorders.
Delays in treatment for psychosis can be associated with poorer outcomes.
Therapeutic drug monitoring is vastly underused in psychiatry but could better inform clinical decision-making.
Although clozapine is often ignored by many clinicians, the antipsychotic should be considered for more patients.
Telepsychiatry training for residents will ensure that the potential of the technology is fully realized.
More Articles by John M. Kane, MD
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Effectiveness of Exercise in Decreasing Depressive Symptoms
- Obsessive Compulsive Disorder Associated With Decreased Educational Attainment
- Neuroactive Steroids May Be Therapeutic Targets for Depression and Anxiety
- Antidepressant Effectiveness for Depression in Schizophrenia
- Dementia Risk Not Associated With Proton Pump Inhibitor Use
- Nutritional Psychiatry: Emerging Evidence and Expert Interview
- Bipolar Disorder, Borderline Personality Disorder May Represent the Same Disorder
- FDA Approval: Once-Monthly Buprenorphine Injection for Opioid Use Disorder
- Posttreatment Brain Effects of Psilocybin in Patients With Treatment-Resistant Depression
- Borderline Personality Disorder: Not Just an Adult Condition
- Psychosis Treatment Failure More Common in Patients With ASD
- Psychiatric Risk for Female Offspring of World War II Finnish Evacuees
- Making a Decision: Using Conscious vs Unconscious Thinking to Solve the Problem
- Adult ADHD May Negatively Affect Fibromyalgia-Related Morbidity
- Depression Screening Tools Accurate in Post-Acute Coronary Syndrome